Rockefeller Capital Management’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-18,533
| Closed | -$153K | – | 1573 |
|
|
2023
Q2 | $153K | Buy |
18,533
+379
| +2% | +$3.12K | ﹤0.01% | 1712 |
|
|
2023
Q1 | $131K | Buy |
18,154
+1,000
| +6% | +$7.22K | ﹤0.01% | 1872 |
|
|
2022
Q4 | $152K | Sell |
17,154
-1,765
| -9% | -$15.6K | ﹤0.01% | 1802 |
|
|
2022
Q3 | $231K | Buy |
18,919
+40
| +0.2% | +$488 | ﹤0.01% | 1586 |
|
|
2022
Q2 | $223K | Buy |
18,879
+2,243
| +13% | +$26.5K | ﹤0.01% | 1592 |
|
|
2022
Q1 | $316K | Buy |
16,636
+15,003
| +919% | +$285K | ﹤0.01% | 1501 |
|
|
2021
Q4 | $43K | Sell |
1,633
-6,260
| -79% | -$165K | ﹤0.01% | 2278 |
|
|
2021
Q3 | $323K | Buy |
7,893
+5,379
| +214% | +$220K | ﹤0.01% | 1413 |
|
|
2021
Q2 | $142K | Buy |
2,514
+465
| +23% | +$26.3K | ﹤0.01% | 1654 |
|
|
2021
Q1 | $86K | Buy |
2,049
+1,018
| +99% | +$42.7K | ﹤0.01% | 1672 |
|
|
2020
Q4 | $72K | Buy |
1,031
+467
| +83% | +$32.6K | ﹤0.01% | 1559 |
|
|
2020
Q3 | $15K | Buy |
+564
| New | +$15K | ﹤0.01% | 1880 |
|
|
2020
Q1 | – | Sell |
-7
| Closed | – | – | 2383 |
|
|
2019
Q4 | $0 | Buy |
+7
| New | – | ﹤0.01% | 2084 |
|